COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in Children Treated With Cranial Radiation for Brain Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02153957
Recruitment Status : Recruiting
First Posted : June 3, 2014
Last Update Posted : February 25, 2020
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

Brief Summary:


- More children with cancer are surviving into adulthood. Some side effects from treatment go away quickly. But some problems may not go away or may only show up months or years later. These problems are called late effects. Late effects can cause difficulties in cognitive functions, such as attention and memory. Physical activity has been found to improve the attention and memory skills of children with Attention Deficit Hyperactivity Disorder (ADHD). Researchers want to see if physical activity can help with these cognitive problems in children with brain tumors.


- To see if physical activity can improve cognitive functions in children who had radiation therapy for a brain tumor.


- Children ages 8 17 who had radiation for a brain tumor at least 2 years ago. They must have access to a computer.


  • Participants will be screened with height, weight, and medical history. They will answer questions about daily physical activities. Their heart will be checked.
  • Participants will go to the clinic for 2 days. They will have a fitness exam and tests about attention, memory, and concentration. They will have blood taken and answer questions. Parents will also answer questions.
  • Participants will be put into 2 groups. For the first 12 weeks, the intervention group will follow a physical activity program. The control group will do their usual physical activities.
  • For the second 12 weeks, the control group will follow the physical activity program. The intervention group will continue the activities on their own. All groups will track their physical activity with an activity monitor and computer.
  • Participants will have a follow-up visit at the clinic after each session. They will repeat some of the tests listed above.
  • The study lasts 24 weeks plus the two follow-up visits. Participants can keep their activity monitor.

Condition or disease Intervention/treatment Phase
Brain Tumor Behavioral: Physical Activity Phase 2

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 156 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: A Randomized Controlled Trial Evaluating an Enhanced Physical Activity Intervention to Improve Cognitive Late Effects in ChildrenTreated With Cranial Radiation for BrainTumors
Actual Study Start Date : August 21, 2014
Estimated Primary Completion Date : December 31, 2020
Estimated Study Completion Date : July 1, 2021

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: 1
Enhanced PA home intervention group for the first 12weeks; followed by 12 weeks of PA maintenance ontheir own.
Behavioral: Physical Activity
12 weeks of enhanced physical activity with Zamzee monitor.

Active Comparator: 2
Usual physical activity (no intervention) for 12 weeks;followed by the enhanced PA home intervention for 12 weeks.
Behavioral: Physical Activity
12 weeks of enhanced physical activity with Zamzee monitor.

Primary Outcome Measures :
  1. Efficacy [ Time Frame: 12 weeks ]
    Efficacy of 12-weeks PA on visual memory

Secondary Outcome Measures :
  1. Examine test scores pre- to post- intervention [ Time Frame: 24 weeks ]
    Examine test scores pre- to post- intervention

  2. Effects of lab treadmill on neurobehavioral functioning [ Time Frame: 2 days ]
    Effects of lab treadmill on neurobehavioral functioning

  3. compare cognitive test scores between groups [ Time Frame: 12 weeks ]
    compare cognitive test scores between groups

  4. effects of 12wk PA on fatigue, sleep and QOL [ Time Frame: 24 weeks ]
    effects of 12wk PA on fatigue, sleep, and QOL

  5. Effects of 12wk PA on cognitive functions [ Time Frame: 24 weeks ]
    Effects of 12wk PA on cognitive functions

  6. Feasibility [ Time Frame: 4 years ]
    To assess the feasibility of various components of the intervention (e.g., ACT sessions, PA monitors) based on the post-study questionnaire/interview and explore relationships between the use of these components and physical activity outcomes

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   8 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

    1. Children ages 8 - 18 years of age, diagnosed with brain tumor in childhood.
    2. Must be at least 1 year post completion of radiation therapy to the brain or brain and spine.
    3. Must be off anti-neoplastic therapy for at least 2 weeks and all therapy-related toxicities should return to baseline or less than or equal to Grade 1 if previously nonexistent.
    4. Have parent-reported or documented difficulties in attention, processing speed, memory, or learning as assessed by the screening questions (a score of at least 3 on any one of the 4 questions or the participant having greater than or equal to 1/2 SD decline in test scores, scores < 85, or special education services or accommodations).
    5. Must have a parent or legal guardian willing to complete the parent proxy behavioral questionnaires and help their child participate in the study procedures at home.
    6. Ability to read and understand the English language.
    7. Have regular access to a computer (either PC or Mac with a built-in USB port).
    8. Must be willing to register online and install the software to use an age-appropriate activity monitor and website which will include sharing some personal identifiable information, to allow the participant to track their physical activity.
    9. Ability of subject or Legally Authorized Representative (LAR) to understand and willingness to sign a written informed consent document.


  1. A child with diffuse intrinsic pontine glioma (DIPG) or recurrent high grade brain tumors will be excluded due to the poor prognosis, making participation for the length of this study difficult.
  2. Significant medical problems, such as severe uncontrolled illnesses, or physical impairments that prohibit the child from exercising at moderate to vigorous levels based on the clinical judgment of the examining physician or nurse practitioner.
  3. Currently engaging in > 3 hours of moderate to vigorous physical activity per week, as reported in the exercise screening questions completed at the pre-study screening evaluation.
  4. Significant cognitive, behavioral, or emotional impairments as judged by an investigator that would prevent the child from understanding or completing the intervention or assessment measures.
  5. A child has plans to start a new treatment for attention/memory problems in the next 3 months.
  6. Currently on or planning to begin active neoplastic therapy, as the side effects may significantly impair ability to participate in physical activity.
  7. Unable to travel to NIH for the evaluations.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02153957

Layout table for location contacts
Contact: Pamela L Wolters, Ph.D. (240) 760-6035

Layout table for location information
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937      
United States, Massachusetts
Dana Farber Cancer Institute Recruiting
Boston, Massachusetts, United States, 02115
Sponsors and Collaborators
National Cancer Institute (NCI)
Layout table for investigator information
Principal Investigator: Pamela L Wolters, Ph.D. National Cancer Institute (NCI)
Additional Information:
Layout table for additonal information
Responsible Party: National Cancer Institute (NCI) Identifier: NCT02153957    
Other Study ID Numbers: 140116
First Posted: June 3, 2014    Key Record Dates
Last Update Posted: February 25, 2020
Last Verified: January 28, 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) ):
Additional relevant MeSH terms:
Layout table for MeSH terms
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases